• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.12% Nasdaq Up 0.71%

    Actavis plc (ACT)

    -NYSE
    295.41 Down 2.95(0.99%) Apr 24, 4:01PM EDT
    |After Hours : 295.25 Down 0.16 (0.05%) Apr 24, 7:41PM EDT
    Add to Portfolio
    Prev Close:298.36
    Open:298.00
    Bid:295.00 x 100
    Ask:297.50 x 800
    1y Target Est:342.89
    Beta:0.78
    Next Earnings Date:11-May-15ACT Earnings announcement
    Day's Range:295.22 - 298.76
    52wk Range:193.00 - 317.72
    Volume:1,983,512
    Avg Vol (3m):3,289,470
    Market Cap:119.64B
    P/E (ttm):N/A
    EPS (ttm):-7.42
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ACT

    Comparison

    Symbol% ChgMkt Cap
    ACTDown 0.99%119.64B
    MYLUp 3.22%37.22B
    NVSDown 1.16%250.13B
    TEVAUp 1.83%54.87B

    Key Statistics

    Forward P/E (1 yr):13.85
    P/S (ttm):6.08
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :17.61
    Quarterly EPS Est (Mar-15) :3.96
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):0.94

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Actavis plc develops, manufactures, and sells generic, brand, and biosimilar pharmaceuticals. It offers over-the-counter products. The company also provides biosimilar products in women’s health, oncology, and other therapeutic categories. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback